Patents by Inventor Christian Loesche

Christian Loesche has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8513249
    Abstract: Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.4% to about 0.6% by weight of brimonidine and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: April 26, 2012
    Date of Patent: August 20, 2013
    Assignee: Galderma Laboratories, L.P.
    Inventors: Michael Graeber, Christian Loesche, Philip Freidenreich, Yin-Sang Liu, Matthew J. Leoni
  • Patent number: 8513247
    Abstract: Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.4% to about 0.6% by weight of brimonidine and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: March 25, 2011
    Date of Patent: August 20, 2013
    Assignee: Galderma Laboratories, L.P.
    Inventors: Michael Graeber, Christian Loesche, Philip Freidenreich, Yin-Sang Liu, Matthew J. Leoni
  • Patent number: 8445543
    Abstract: Adapalene or a pharmaceutically acceptable salt thereof formulated into a pharmaceutical composition is useful for reducing the number of acne lesions, via daily topical application, in combination or in association with benzoyl peroxide (BPO); such treatment may be via administration of a pharmaceutical composition combining adapalene and BPO or by a concomitant application of two pharmaceutical compositions, one containing adapalene and the other containing BPO.
    Type: Grant
    Filed: November 30, 2011
    Date of Patent: May 21, 2013
    Assignee: Galderma Research & Development
    Inventors: Marie-line Abou-Chacra Vernet, Denis Gross, Christian Loesche, Michel Poncet
  • Patent number: 8410102
    Abstract: Methods and products for treating or preventing erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical aqueous gel composition comprising about 0.01% to about 10% by weight of at least one ?-adrenergic receptor agonist and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: March 25, 2011
    Date of Patent: April 2, 2013
    Assignee: Galderma Laboratories Inc.
    Inventors: Michael Graeber, Christian Loesche, Philip Freidenreich, Jack A. Dejovin, Isabelle Jean Dejovin, Yin-Sang Liu, Matthew James Leoni
  • Publication number: 20130071489
    Abstract: Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.3% to about 10% by weight of brimonidine and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: March 25, 2011
    Publication date: March 21, 2013
    Applicant: GALDERMA RESEARCH & DEVELOPMENT SNC
    Inventors: Michael Graeber, Christian Loesche, Philip Freidenreich, Yin Liu, Matthew James Leoni
  • Publication number: 20130059857
    Abstract: Improved methods and compositions for safe and effective treatment of telangiectasia or a symptom associated with telangiectasia in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.3% to about 10% by weight of brimonidine and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: March 25, 2011
    Publication date: March 7, 2013
    Applicant: GALDERMA RESEARCH & DEVELOPMENT SNC
    Inventors: Michael Graeber, Christian Loesche, Philip Freidenreich, Yin Liu, Matthew James Leoni
  • Publication number: 20120214816
    Abstract: Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.4% to about 0.6% by weight of brimonidine and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: April 26, 2012
    Publication date: August 23, 2012
    Applicant: Galdema R&D Inc.
    Inventors: Michael GRAEBER, Christian LOESCHE, Philip FREIDENREICH, Yin-Sang LIU, Matthew J. LEONI
  • Publication number: 20120136059
    Abstract: Adapalene or a pharmaceutically acceptable salt thereof formulated into a pharmaceutical composition is useful for reducing the number of acne lesions, via daily topical application, in combination or in association with benzoyl peroxide (BPO); such treatment may be via administration of a pharmaceutical composition combining adapalene and BPO or by a concomitant application of two pharmaceutical compositions, one containing adapalene and the other containing BPO.
    Type: Application
    Filed: November 30, 2011
    Publication date: May 31, 2012
    Applicant: Galderma Research & Development
    Inventors: Marie-line ABOU-CHACRA VERNET, Denis Gross, Christian Loesche, Michel Poncet
  • Publication number: 20120115947
    Abstract: Acne lesions, whether of inflammatory and/or non-inflammatory type, are simultaneously or sequentially treated and their number reduced, via daily topical regimen, with the combination or association of adapalene or pharmaceutically acceptable salt thereof and benzoyl peroxide (BPO).
    Type: Application
    Filed: January 17, 2012
    Publication date: May 10, 2012
    Applicant: Galderma Research & Development
    Inventors: Marie-Line Abou Chacra Vernet, Denis Gross, Christian Loesche, Michel Poncet
  • Publication number: 20120059063
    Abstract: Adapalene or a pharmaceutically acceptable salt thereof formulated into a pharmaceutical composition is useful for reducing the number of acne lesions, via daily topical application, in combination or in association with benzoyl peroxide (BPO); such treatment may be via administration of a pharmaceutical composition combining adapalene and BPO or by a concomitant application of two pharmaceutical compositions, one containing adapalene and the other containing BPO.
    Type: Application
    Filed: November 14, 2011
    Publication date: March 8, 2012
    Applicant: Galderma Research & Development
    Inventors: Marie-line ABOU-CHACRA VERNET, Denis Gross, Christian Loesche, Michel Poncet
  • Patent number: 8129362
    Abstract: Acne lesions, whether of inflammatory and/or non-inflammatory type, are simultaneously or sequentially treated and their number reduced, via daily topical regimen, with the combination or association of adapalene or pharmaceutically acceptable salt thereof and benzoyl peroxide (BPO).
    Type: Grant
    Filed: July 13, 2007
    Date of Patent: March 6, 2012
    Assignee: Galderma Research & Development
    Inventors: Marie-Line Abou Chacra Vernet, Denis Gross, Christian Loesche, Michel Poncet
  • Patent number: 8080537
    Abstract: Adapalene or a pharmaceutically acceptable salt thereof formulated into a pharmaceutical composition is useful for reducing the number of acne lesions, via daily topical application, in combination or in association with benzoyl peroxide (BPO); such treatment may be via administration of a pharmaceutical composition combining adapalene and BPO or by a concomitant application of two pharmaceutical compositions, one containing adapalene and the other containing BPO.
    Type: Grant
    Filed: May 28, 2009
    Date of Patent: December 20, 2011
    Assignee: Galderma Research & Development
    Inventors: Marie-line Abou-Chacra Vernet, Denis Gross, Christian Loesche, Michel Poncet
  • Patent number: 8071644
    Abstract: Adapalene or a pharmaceutically acceptable salt thereof formulated into a pharmaceutical composition is useful for reducing the number of acne lesions, via daily topical application, in combination or in association with benzoyl peroxide (BPO); such treatment may be via administration of a pharmaceutical composition combining adapalene and BPO or by a concomitant application of two pharmaceutical compositions, one containing adapalene and the other containing BPO.
    Type: Grant
    Filed: January 13, 2009
    Date of Patent: December 6, 2011
    Assignee: Galderma Research & Development
    Inventors: Marie-line Abou-Chacra Vernet, Denis Gross, Christian Loesche, Michel Poncet
  • Publication number: 20110288096
    Abstract: Methods and products for treating or preventing erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical aqueous gel composition comprising about 0.01% to about 10% by weight of at least one ?-adrenergic receptor agonist and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: March 25, 2011
    Publication date: November 24, 2011
    Applicant: GALDERMA LABORATORIES INC.
    Inventors: Michael GRAEBER, Christian LOESCHE, Philip FREIDENREICH, Jack A. DEJOVIN, Isabelle Jean DEJOVIN, Yin-Sang LIU, Matthew J. LEONI
  • Publication number: 20110286944
    Abstract: Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.4% to about 0.6% by weight of brimonidine and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: March 25, 2011
    Publication date: November 24, 2011
    Applicant: GALDERMA R&D INC.
    Inventors: Michael GRAEBER, Christian LOESCHE, Philip FREIDENREICH, Yin-Sang LIU, Matthew J. LEONI
  • Publication number: 20110224216
    Abstract: A method of treating or preventing acute erythema in a human in need thereof by topical administration of an effective amount of an alpha adrenergic receptor agonist or pharmaceutically acceptable salt thereof is claimed. The preferred alpha adrenergic receptor agonist is brimonidine. A method of preventing secondary inflammation caused by acute erythema by topical administration of an effective amount of an alpha adrenergic receptor agonist or a pharmaceutically acceptable salt thereof is also claimed.
    Type: Application
    Filed: October 19, 2010
    Publication date: September 15, 2011
    Applicant: GALDERMA LABORATORIES INC.
    Inventors: Philippe Andres, Christian Loesche, Michael Graeber
  • Publication number: 20090298798
    Abstract: Adapalene or a pharmaceutically acceptable salt thereof formulated into a pharmaceutical composition is useful for reducing the number of acne lesions, via daily topical application, in combination or in association with benzoyl peroxide (BPO); such treatment may be via administration of a pharmaceutical composition combining adapalene and BPO or by a concomitant application of two pharmaceutical compositions, one containing adapalene and the other containing BPO.
    Type: Application
    Filed: May 28, 2009
    Publication date: December 3, 2009
    Applicant: Galderma Research & Development
    Inventors: Marie-line Abou-Chacra Vernet, Denis Gross, Christian Loesche, Michel Poncet
  • Publication number: 20090253788
    Abstract: Adapalene or a pharmaceutically acceptable salt thereof formulated into a pharmaceutical composition is useful for reducing the number of acne lesions, via daily topical application, in combination or in association with benzoyl peroxide (BPO); such treatment may be via administration of a pharmaceutical composition combining adapalene and BPO or by a concomitant application of two pharmaceutical compositions, one containing adapalene and the other containing BPO.
    Type: Application
    Filed: January 13, 2009
    Publication date: October 8, 2009
    Applicant: GALDERMA RESEARCH & DEVELOPMENT.
    Inventors: Marie-line Abou-Chacra Vernet, Denis Gross, Christian Loesche, Michel Poncet
  • Publication number: 20090075958
    Abstract: Seborrheic dermatitis is effectively/safely treated by topically applying a corticosteroid shampoo, notably a clobetasol propionate shampoo, onto the scalp of a human subject afflicted therewith.
    Type: Application
    Filed: September 22, 2008
    Publication date: March 19, 2009
    Inventors: Florence Bistuer, Christian Loesche, Pascale Soto
  • Publication number: 20090048289
    Abstract: Tropisetron or salt thereof, formulated into diverse pharmaceutical/dermatological compositions, is useful for the treatment of a variety of inflammatory skin disorders/diseases, e.g., eczema, psoriasis, rosacea, acne vulgaris, ulcers, seborrhoeic dermatitis and irritations induced by chemical, physical or mechanical agents, notably rosacea.
    Type: Application
    Filed: August 18, 2008
    Publication date: February 19, 2009
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: NADEGE TREMEL, JEAN-DOMINIQUE PIERRET, FABRIZIO DOLFI, CHRISTIAN LOESCHE